'Dis­con­nect the bas­tard­s' — one biotech's plan to break can­cer cell­s' uni­fied de­fens­es

Chemother­a­py and ra­dio­ther­a­py are the cur­rent glad­i­a­tors of can­cer treat­ment, but they come with well-known lim­i­ta­tions and side-ef­fects. The emer­gence of im­munother­a­py — a fe­ro­cious new …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER